Literature DB >> 19955948

Quantitative analysis of heparanase gene expression in normal cervical, cervical intraepithelial neoplastic, and cervical carcinoma tissues.

Eugene Varchalama1, Alexander Rodolakis, Areti Strati, Theocharis Papageorgiou, Christos Valavanis, George Vorgias, Evi Lianidou, Aristidis Antsaklis.   

Abstract

Heparanase is an endoglycosidase that specifically cleaves heparan sulfate side chains of heparan sulfate proteoglycans, the major proteoglycans in the extracellular matrix and cell surfaces. Traditionally, heparanase activity was implicated in cellular invasion associated with angiogenesis, inflammation, and cancer metastasis. More recently, heparanase up-regulation was documented in an increasing number of primary human tumors. Iotan this study, we sought to investigate the expression of heparanase messenger RNA (mRNA) in normal cervical tissue and intraepithelial cervical lesion and its clinicopathologic importance in invasive cervical cancer. Gene expression of heparanase was assessed by quantitative real-time reverse transcriptase polymerase chain reaction in 28 normal cervical, 26 intraepithelial neoplastic, and 48 cervical cancer tissue samples. Heparanase mRNA expression was different between the 3 groups and lower in normal cervical specimens in relationship with intraepithelial cervical lesions and invasive cervical cancer tissue samples (P = 0.048). Gradually increasing expression of heparanase was evident as the cells progressed from low-grade to high-grade squamous intraepithelial lesions (P = 0.002). In invasive cervical cancer cases, there was a direct correlation between heparanase expression and tumor size (P = 0.002). In cases treated with radical hysterectomy and pelvic lymphadenectomy, the heparanase mRNA expression was significantly higher in tumors exhibiting lymph vascular space invasion (P = 0.044) and in cases with big tumor size (P = 0.005). In our study, we did not find any significant correlation between disease-free and overall survival rates and expression of heparanase (P = 0.396 and P = 0.712, respectively). The results of this study suggest that the gene expression of heparanase in cervical cancer enhances growth, invasion, and angiogenesis of the tumor and may have therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955948     DOI: 10.1111/IGC.0b013e3181ae3f40

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

1.  Heparanase promotes human gastric cancer cells migration and invasion by increasing Src and p38 phosphorylation expression.

Authors:  Xiu Mei Ma; Zhi Hua Shen; Zhi Yao Liu; Fang Wang; Ling Hai; Lin Tao Gao; Hai Sheng Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA.

Authors:  Kerryn Mason; Peter Meikle; John Hopwood; Maria Fuller
Journal:  Metabolites       Date:  2014-12-11

3.  Hallmarks of glycogene expression and glycosylation pathways in squamous and adenocarcinoma cervical cancer.

Authors:  Patricia Martinez-Morales; Irene Morán Cruz; Lorena Roa-de la Cruz; Paola Maycotte; Juan Salvador Reyes Salinas; Victor Javier Vazquez Zamora; Claudia Teresita Gutierrez Quiroz; Alvaro Jose Montiel-Jarquin; Verónica Vallejo-Ruiz
Journal:  PeerJ       Date:  2021-08-31       Impact factor: 2.984

4.  Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression.

Authors:  Li-Ping Liu; Xi-Ping Sheng; Tian-Kui Shuai; Yong-Xun Zhao; Bin Li; Yu-Min Li
Journal:  World J Gastroenterol       Date:  2018-10-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.